ZA200809112B - N-oxides of pyridylmethylpiperazine and -piperidine derivatives - Google Patents

N-oxides of pyridylmethylpiperazine and -piperidine derivatives

Info

Publication number
ZA200809112B
ZA200809112B ZA200809112A ZA200809112A ZA200809112B ZA 200809112 B ZA200809112 B ZA 200809112B ZA 200809112 A ZA200809112 A ZA 200809112A ZA 200809112 A ZA200809112 A ZA 200809112A ZA 200809112 B ZA200809112 B ZA 200809112B
Authority
ZA
South Africa
Prior art keywords
pyridylmethylpiperazine
oxides
piperidine derivatives
piperidine
derivatives
Prior art date
Application number
ZA200809112A
Other languages
English (en)
Inventor
Aar Marcel P M Van
Amsterdam Peter H Van
Gerrit A Barf
Bakker Johan Antoine
Den Besten Cathaline
Arnoldus H J Herremans
Zorgdrager Jan
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37198739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200809112(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of ZA200809112B publication Critical patent/ZA200809112B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200809112A 2006-05-02 2008-10-23 N-oxides of pyridylmethylpiperazine and -piperidine derivatives ZA200809112B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06113393 2006-05-02

Publications (1)

Publication Number Publication Date
ZA200809112B true ZA200809112B (en) 2009-07-29

Family

ID=37198739

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809112A ZA200809112B (en) 2006-05-02 2008-10-23 N-oxides of pyridylmethylpiperazine and -piperidine derivatives

Country Status (16)

Country Link
EP (1) EP2024363B1 (enExample)
JP (1) JP2009535374A (enExample)
CN (1) CN101432279A (enExample)
AR (1) AR060832A1 (enExample)
AU (1) AU2007247251B2 (enExample)
BR (1) BRPI0710792A2 (enExample)
CA (1) CA2649479A1 (enExample)
CL (1) CL2007001245A1 (enExample)
EA (1) EA200870492A1 (enExample)
MX (1) MX2008013887A (enExample)
PE (1) PE20080064A1 (enExample)
SA (1) SA07280218B1 (enExample)
TW (1) TW200811150A (enExample)
UA (1) UA96756C2 (enExample)
WO (1) WO2007128694A1 (enExample)
ZA (1) ZA200809112B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711236B (zh) * 2007-04-12 2012-10-31 Nsab神经研究瑞典公司分公司 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物
MX347209B (es) 2011-12-08 2017-04-19 Teva Pharmaceuticals Int Gmbh La sal de bromhidrato de pridopidina.
AU2013243461A1 (en) 2012-04-04 2014-11-06 Teva Pharmaceuticals International Gmbh Pharmaceutical compositions for combination therapy
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
TW530054B (en) 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds

Also Published As

Publication number Publication date
JP2009535374A (ja) 2009-10-01
UA96756C2 (en) 2011-12-12
AR060832A1 (es) 2008-07-16
CA2649479A1 (en) 2007-11-15
MX2008013887A (es) 2009-01-29
AU2007247251A1 (en) 2007-11-15
TW200811150A (en) 2008-03-01
BRPI0710792A2 (pt) 2011-06-21
EP2024363B1 (en) 2012-08-01
EA200870492A1 (ru) 2009-04-28
WO2007128694A1 (en) 2007-11-15
CL2007001245A1 (es) 2008-05-30
AU2007247251B2 (en) 2011-11-03
SA07280218B1 (ar) 2010-10-03
EP2024363A1 (en) 2009-02-18
PE20080064A1 (es) 2008-03-19
CN101432279A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
IL193265A0 (en) Quinoline derivatives
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
ZA200806809B (en) Pyridine-2-carboxamide derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
IL198645A0 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
GB0622472D0 (en) Novel heterocyclic derivatives
PL2061889T3 (pl) Zwiększanie poziomów alkaloidów nikotynowych
ZA200807460B (en) Spiroindolinone derivatives
IL197239A0 (en) Phenyloxyaniline derivatives
IL194758A0 (en) N-oxides of pyridylmethylpipertazine and-piperidine derivatives
HUP0500463A3 (en) Pyridine derivatives of dialkyl-oxindoles
ZA200806877B (en) Quinoline Derivatives
HU0500462D0 (en) Pyridinyl derivatives of alkyl-oxindoles
GB0610019D0 (en) Benzotriazepinone derivatives
GB0610018D0 (en) Benzotriazepinone derivatives